Log in to save to my catalogue

Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain i...

Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2862200102

Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury

About this item

Full title

Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury

Publisher

Richmond: Wiley Subscription Services, Inc

Journal title

Clinical and experimental pharmacology & physiology, 2023-12, Vol.50 (12), p.927-935

Language

English

Formats

Publication information

Publisher

Richmond: Wiley Subscription Services, Inc

More information

Scope and Contents

Contents

Ferroptosis is a recently discovered non‐apoptotic form of cellular death. Acyl‐CoA synthetase long‐chain family number 4 (ACSL4) is necessary for iron‐dependent cellular death, and reactive oxygen species (ROS) produced by ACSL4 are the executioners of ferroptosis. Rosiglitazone improves ferroptosis by inhibiting ACSL4. There is no research indica...

Alternative Titles

Full title

Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2862200102

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2862200102

Other Identifiers

ISSN

0305-1870

E-ISSN

1440-1681

DOI

10.1111/1440-1681.13815

How to access this item